Elevated levels of CCR5 ligands are observed in MS lesions, and circulating DCs in MS patients have been shown to have increased CCR5 expression, suggesting that CCR5 may facilitate DC infiltration into inflamed CNS tissues [81]. The gene discussed is CCR5; the disease is myeloid sarcoma.